Active Biotech AB (publ)

Active Biotech AB (publ)verified

ACTI.ST

Price:

$0.0478

Market Cap:

$58.80M

Active Biotech AB (publ), a biotechnology company, develops pharmaceutical products the treatment of oncology and immunology diseases in Sweden. It is developing Tasquinimod, a small molecule immuno-modulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that is in phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an anti-cancer immunotherapy, which is in phase Ib/II clinical trial to treat patients with advanced solid tumors. The company has a licensing agreement with NeoTX Therapeutics Ltd. for the development and commercialization of Naptumomab for cancer immunotherapy. Active Bio...[Read more]

Industry

Biotechnology

IPO Date

2003-12-19

Stock Exchange

STO

Ticker

ACTI.ST

The Enterprise Value as of December 2025 (TTM) for Active Biotech AB (publ) (ACTI.ST) is 50.10M

According to Active Biotech AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 50.10M. This represents a change of -62.37% compared to the average of 133.13M of the last 4 quarters.

Active Biotech AB (publ) (ACTI.ST) Historical Enterprise Value (quarterly & annually)

How has ACTI.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Active Biotech AB (publ) over the last ten years is 153.23M. The current 50.10M Enterprise Value has changed 3.17% with respect to the historical average. Over the past ten years (40 quarters), ACTI.ST's Enterprise Value was at its highest in in the September 2017 quarter at 417.46M. The Enterprise Value was at its lowest in in the March 2021 quarter at 21.46M.

Quarterly (TTM)
Annual

Average

153.23M

Median

95.43M

Minimum

21.53M

Maximum

356.22M

Active Biotech AB (publ) (ACTI.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Active Biotech AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 41.27%

Maximum Annual Enterprise Value = 356.22M

Minimum Annual Increase = -1047.43%

Minimum Annual Enterprise Value = 21.53M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202421.53M-11.36%
202324.29M-63.05%
202265.73M-4.44%
202168.79M-31.02%
202099.73M9.45%
201991.12M-74.42%
2018356.22M41.27%
2017252.15M-5.61%
2016267.14M-6.46%
2015285.60M-1047.43%

Active Biotech AB (publ) (ACTI.ST) Average Enterprise Value

How has ACTI.ST Enterprise Value performed in the past?

The current Enterprise Value of Active Biotech AB (publ) (ACTI.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

37.18M

5-year avg

56.01M

10-year avg

153.23M

Active Biotech AB (publ) (ACTI.ST) Enterprise Value vs. Peers

How is ACTI.ST’s Enterprise Value compared to its peers?

Active Biotech AB (publ)’s Enterprise Value is less than Biovica International AB (publ) (109.21M), greater than NextCell Pharma AB (37.36M), less than Pila Pharma AB (publ) (97.19M), less than Nanologica AB (publ) (69.37M), less than Iconovo AB (publ) (51.50M), less than Sprint Bioscience AB (publ) (144.16M), less than Biosergen AB (77.10M), greater than Alligator Bioscience AB (publ) (25.98M), less than Immunovia AB (publ) (73.05M), greater than Spago Nanomedical AB (publ) (23.92M),

Build a custom stock screener for Active Biotech AB (publ) (ACTI.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Active Biotech AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Active Biotech AB (publ) (ACTI.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Active Biotech AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Active Biotech AB (publ)'s Enterprise Value?

What is the highest Enterprise Value for Active Biotech AB (publ) (ACTI.ST)?

What is the 3-year average Enterprise Value for Active Biotech AB (publ) (ACTI.ST)?

What is the 5-year average Enterprise Value for Active Biotech AB (publ) (ACTI.ST)?

How does the current Enterprise Value for Active Biotech AB (publ) (ACTI.ST) compare to its historical average?